Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Chengke Xie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7986-7226; OpenAlex author ID A5102860892. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2024: 3 papers · 2025: 3 papers

Papers 6

  1. Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. Co-author DOI 10.1016/j.drup.2025.101240↗
  2. Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy. Co-author DOI 10.1016/j.drup.2025.101292↗
  3. TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. Co-author DOI 10.1158/0008-5472.can-24-4784↗
  4. cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mTORC1 axis. Co-author DOI 10.1038/s41419-024-07138-y↗
  5. Necroptosis enhances 'don't eat me' signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis. Co-author DOI 10.1038/s41467-024-50450-6↗
  6. Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer. Co-author DOI 10.1186/s12943-024-02128-2↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cheng‐Yu Liao · 6 shared papers, 2024–2025 · strength 1.14
  2. Zuwei Wang · 6 shared papers, 2024–2025 · strength 1.14
  3. Shi Chen · 6 shared papers, 2024–2025 · strength 1.14
  4. Shun‐Cang Zhu · 5 shared papers, 2024–2025 · strength 0.96
  5. Yongding Wu · 5 shared papers, 2024–2025 · strength 0.96
  6. Hong-Yi Lin · 4 shared papers, 2024–2025 · strength 0.77
  7. Ge Li · 3 shared papers, 2024–2025 · strength 0.59
  8. Haoxiang Zhang · 2 shared papers, 2025 · strength 0.40
  9. Ge Li · 1 shared paper, 2025 · strength 0.20
  10. Yu Pan · 1 shared paper, 2025 · strength 0.20
  11. Chun Zhang · 1 shared paper, 2025 · strength 0.20
  12. Yanling Chen · 1 shared paper, 2024 · strength 0.18
  13. Huixing Chen · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.